Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex

J. R. Slupsky, J. G. Seehafer, S. C. Tang, A. Masellis-Smith, A. R E Shaw

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Monoclonal antibodies to the CD9 antigen are powerful platelet agonists. We report here the novel finding that the anti-CD9 monoclonal antibodies 50H.19 and ALB6 promote physical association between CD9 antigen and the glycoprotein IIb-IIIa complex (GPIIb-IIIa) component of the platelet fibrinogen receptor. The monoclonal antibodies do not consistently immunoprecipitate proteins other than CD9 from 125I-labeled human platelets even if the platelets are first treated with the homobifunctional cross-linking reagent dithiobis(succinimidyl propionate), indicating that CD9 antigen is not physically associated with other membrane proteins in the resting state. However, the addition of agonistic concentrations of either monoclonal antibody before cross-linking results in the co-precipitation of proteins corresponding in mobility and peptide composition to GPIIb, and GPIIIa. The association of CD9 with the GPIIb-IIIa complex is unaffected by a combination of aspirin and ADP scavengers sufficient to abrogate anti-CD9 monoclonal antibody-induced platelet aggregation, and is therefore not dependent upon thromboxane- and ADP-mediated pathways of intracellular signalling. The specificity of the association is demonstrated by the lack of other co-precipitating major proteins, by the requirement for induction by anti-CD9 monoclonal antibodies, and by the failure to promote reciprocal association with either of the anti-GPIIb-IIIa complex monoclonal antibodies P2 and HuP1-m1a.

Original languageEnglish (US)
Pages (from-to)12289-12293
Number of pages5
JournalJournal of Biological Chemistry
Volume264
Issue number21
StatePublished - Jan 1 1989

Fingerprint

CD9 Antigen
Integrin beta3
Platelet Membrane Glycoproteins
Platelet Glycoprotein GPIIb-IIIa Complex
Platelets
Monoclonal Antibodies
Association reactions
Blood Platelets
Adenosine Diphosphate
Fibrinogen Receptors
Cross-Linking Reagents
Proteins
Thromboxanes
Coprecipitation
Platelet Aggregation
Aspirin
Membrane Proteins
Agglomeration
Peptides

ASJC Scopus subject areas

  • Biochemistry

Cite this

Slupsky, J. R., Seehafer, J. G., Tang, S. C., Masellis-Smith, A., & Shaw, A. R. E. (1989). Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. Journal of Biological Chemistry, 264(21), 12289-12293.

Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. / Slupsky, J. R.; Seehafer, J. G.; Tang, S. C.; Masellis-Smith, A.; Shaw, A. R E.

In: Journal of Biological Chemistry, Vol. 264, No. 21, 01.01.1989, p. 12289-12293.

Research output: Contribution to journalArticle

Slupsky, J. R. ; Seehafer, J. G. ; Tang, S. C. ; Masellis-Smith, A. ; Shaw, A. R E. / Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. In: Journal of Biological Chemistry. 1989 ; Vol. 264, No. 21. pp. 12289-12293.
@article{ed695b1f8eec444fa3e901d3fde5fc2a,
title = "Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex",
abstract = "Monoclonal antibodies to the CD9 antigen are powerful platelet agonists. We report here the novel finding that the anti-CD9 monoclonal antibodies 50H.19 and ALB6 promote physical association between CD9 antigen and the glycoprotein IIb-IIIa complex (GPIIb-IIIa) component of the platelet fibrinogen receptor. The monoclonal antibodies do not consistently immunoprecipitate proteins other than CD9 from 125I-labeled human platelets even if the platelets are first treated with the homobifunctional cross-linking reagent dithiobis(succinimidyl propionate), indicating that CD9 antigen is not physically associated with other membrane proteins in the resting state. However, the addition of agonistic concentrations of either monoclonal antibody before cross-linking results in the co-precipitation of proteins corresponding in mobility and peptide composition to GPIIb, and GPIIIa. The association of CD9 with the GPIIb-IIIa complex is unaffected by a combination of aspirin and ADP scavengers sufficient to abrogate anti-CD9 monoclonal antibody-induced platelet aggregation, and is therefore not dependent upon thromboxane- and ADP-mediated pathways of intracellular signalling. The specificity of the association is demonstrated by the lack of other co-precipitating major proteins, by the requirement for induction by anti-CD9 monoclonal antibodies, and by the failure to promote reciprocal association with either of the anti-GPIIb-IIIa complex monoclonal antibodies P2 and HuP1-m1a.",
author = "Slupsky, {J. R.} and Seehafer, {J. G.} and Tang, {S. C.} and A. Masellis-Smith and Shaw, {A. R E}",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "264",
pages = "12289--12293",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "21",

}

TY - JOUR

T1 - Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex

AU - Slupsky, J. R.

AU - Seehafer, J. G.

AU - Tang, S. C.

AU - Masellis-Smith, A.

AU - Shaw, A. R E

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Monoclonal antibodies to the CD9 antigen are powerful platelet agonists. We report here the novel finding that the anti-CD9 monoclonal antibodies 50H.19 and ALB6 promote physical association between CD9 antigen and the glycoprotein IIb-IIIa complex (GPIIb-IIIa) component of the platelet fibrinogen receptor. The monoclonal antibodies do not consistently immunoprecipitate proteins other than CD9 from 125I-labeled human platelets even if the platelets are first treated with the homobifunctional cross-linking reagent dithiobis(succinimidyl propionate), indicating that CD9 antigen is not physically associated with other membrane proteins in the resting state. However, the addition of agonistic concentrations of either monoclonal antibody before cross-linking results in the co-precipitation of proteins corresponding in mobility and peptide composition to GPIIb, and GPIIIa. The association of CD9 with the GPIIb-IIIa complex is unaffected by a combination of aspirin and ADP scavengers sufficient to abrogate anti-CD9 monoclonal antibody-induced platelet aggregation, and is therefore not dependent upon thromboxane- and ADP-mediated pathways of intracellular signalling. The specificity of the association is demonstrated by the lack of other co-precipitating major proteins, by the requirement for induction by anti-CD9 monoclonal antibodies, and by the failure to promote reciprocal association with either of the anti-GPIIb-IIIa complex monoclonal antibodies P2 and HuP1-m1a.

AB - Monoclonal antibodies to the CD9 antigen are powerful platelet agonists. We report here the novel finding that the anti-CD9 monoclonal antibodies 50H.19 and ALB6 promote physical association between CD9 antigen and the glycoprotein IIb-IIIa complex (GPIIb-IIIa) component of the platelet fibrinogen receptor. The monoclonal antibodies do not consistently immunoprecipitate proteins other than CD9 from 125I-labeled human platelets even if the platelets are first treated with the homobifunctional cross-linking reagent dithiobis(succinimidyl propionate), indicating that CD9 antigen is not physically associated with other membrane proteins in the resting state. However, the addition of agonistic concentrations of either monoclonal antibody before cross-linking results in the co-precipitation of proteins corresponding in mobility and peptide composition to GPIIb, and GPIIIa. The association of CD9 with the GPIIb-IIIa complex is unaffected by a combination of aspirin and ADP scavengers sufficient to abrogate anti-CD9 monoclonal antibody-induced platelet aggregation, and is therefore not dependent upon thromboxane- and ADP-mediated pathways of intracellular signalling. The specificity of the association is demonstrated by the lack of other co-precipitating major proteins, by the requirement for induction by anti-CD9 monoclonal antibodies, and by the failure to promote reciprocal association with either of the anti-GPIIb-IIIa complex monoclonal antibodies P2 and HuP1-m1a.

UR - http://www.scopus.com/inward/record.url?scp=0024349131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024349131&partnerID=8YFLogxK

M3 - Article

C2 - 2745443

AN - SCOPUS:0024349131

VL - 264

SP - 12289

EP - 12293

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -